全文获取类型
收费全文 | 18732篇 |
免费 | 1398篇 |
国内免费 | 43篇 |
专业分类
耳鼻咽喉 | 171篇 |
儿科学 | 522篇 |
妇产科学 | 336篇 |
基础医学 | 2458篇 |
口腔科学 | 658篇 |
临床医学 | 1833篇 |
内科学 | 4269篇 |
皮肤病学 | 188篇 |
神经病学 | 1767篇 |
特种医学 | 732篇 |
外国民族医学 | 1篇 |
外科学 | 2290篇 |
综合类 | 390篇 |
一般理论 | 16篇 |
预防医学 | 1552篇 |
眼科学 | 516篇 |
药学 | 1308篇 |
中国医学 | 10篇 |
肿瘤学 | 1156篇 |
出版年
2023年 | 68篇 |
2022年 | 93篇 |
2021年 | 249篇 |
2020年 | 143篇 |
2019年 | 245篇 |
2018年 | 282篇 |
2017年 | 235篇 |
2016年 | 260篇 |
2015年 | 305篇 |
2014年 | 438篇 |
2013年 | 786篇 |
2012年 | 1039篇 |
2011年 | 1106篇 |
2010年 | 596篇 |
2009年 | 610篇 |
2008年 | 1113篇 |
2007年 | 1222篇 |
2006年 | 1245篇 |
2005年 | 1242篇 |
2004年 | 1151篇 |
2003年 | 1115篇 |
2002年 | 1115篇 |
2001年 | 273篇 |
2000年 | 255篇 |
1999年 | 263篇 |
1998年 | 277篇 |
1997年 | 246篇 |
1996年 | 216篇 |
1995年 | 227篇 |
1994年 | 186篇 |
1993年 | 175篇 |
1992年 | 203篇 |
1991年 | 174篇 |
1990年 | 199篇 |
1989年 | 158篇 |
1988年 | 193篇 |
1987年 | 186篇 |
1986年 | 163篇 |
1985年 | 175篇 |
1984年 | 166篇 |
1983年 | 148篇 |
1982年 | 196篇 |
1981年 | 197篇 |
1980年 | 152篇 |
1979年 | 130篇 |
1978年 | 99篇 |
1977年 | 81篇 |
1976年 | 72篇 |
1975年 | 69篇 |
1974年 | 86篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
Barry L. Carter Pharm.D. FCCP Debra J. Barnette Pharm.D. Elizabeth Chrischilles Ph.D. Gordon J. Mazzotti B.S. Ziad J. Asali M.D. 《Pharmacotherapy》1997,17(6):1274-1285
We evaluated blood pressure control, quality of life, quality of care, and satisfaction of patients who were monitored by specially trained community pharmacists in a group medical practice. After participating in an intensive skill development program, pharmacists performed in an interdisciplinary team in a rural clinic. The primary objective was assessed by evaluating outcome variables at 6 months compared with baseline in 25 patients randomly assigned to a study group. A control group of 26 patients was also evaluated to determine if outcome variables remained constant from baseline to 6 months. Systolic blood pressure was reduced in the study group (151 mm Hg baseline, 140 mm Hg at 6 mo, p<0.001) and diastolic blood pressure was significantly lower at 2, 4, and 5 months compared with baseline. Ratings from a blinded peer review panel indicated significant improvement in the appropriateness of the blood pressure regimen, going from 8.7 ± 4.7 to 10.9 ± 4.5 in the study group (p<0.01), but they did not change in the control group. Several quality of life scores improved significantly in the study group after 6 months (p<0.05). These included physical functioning (61.6 vs 70.7), physical role limitations (56.8 vs 72.8), and bodily pain (60.0 vs 71.7) at baseline and 6 months, respectively. There were no significant changes in the control group. Patient satisfaction scores were consistently higher in the study group at the end of the study. Our results indicate that when community pharmacists in a clinic setting are trained and included as members of the primary care team, significant improvements in blood pressure control, quality of life, and patient satisfaction can be achieved. 相似文献
93.
94.
Kenneth C. Chu Barry A. Miller Eric J. Feuer Benjamin F. Hankey 《Journal of clinical epidemiology》1994,47(12):1451-1461
U.S. cancer mortality data derived from information recorded on death certificates are frequently relied upon as an indicator of progress against cancer. A limitation of this measure is the lack of information pertaining to the onset of disease, such as year-of-diagnosis, age-at-diagnosis, stage of disease at diagnosis and histology of lesions. However, population-based cancer registries collect these types of data and allow the calculation of an incidence-file based mortality rate. This incidence-based mortality rate allows a partitioning of mortality by variables associated with the cancer onset. Breast cancer incidence-based mortality measures are created and compared to mortality rates based on death certificates over a comparable time period. Novel mortality measures, such as mortality rates by stage-at-diagnosis, age-at-diagnosis and year-of-diagnosis, are used to illustrate the value of this approach. 相似文献
95.
The purpose of this study was to evaluate the ability of MRI to identify a primary site of malignancy in the breast of patients who present clinically with ipsilateral lymph nodes containing metastatic carcinoma but whose physical and mammographic examination are negative. MRI of the breast was performed on four patients using a variety of imaging parameters, all with and without gadolinium contrast. All patients had biopsy-proven adenocarcinoma of the ipsilateral axilla, with negative physical and mammographic examinations. Foci of enhancement assessed visually on precontrast and postcontrast scans (n = 1) and on substraction studies (n = 3) were considered suspicious under the clinical circumstances defined for this study. Lesions identified on MRI were re-identified on ultrasound examination and either preoperative localization for excisional biopsy or tissue sampling was performed. Surgery was performed and histopathologic correlation was obtained in all cases. Primary sites of breast carcinoma were identified in all four patients, with multiple sites of malignancy identified in three of four patients. Breast conservation therapy was made possible for three of four patients based on the results of the MRI study showing sites of malignancy and no features of cancer elsewhere in the breast. Follow-up data of 1, 2, and 5 years of these patients show no evidence of recurrent disease. MRI of the breast is a useful technique for identifying primary sites of malignancy in patients presenting with ipsilateral lymph nodes positive for metastatic adenocarcinoma when the physical and mammographic examinations are negative. 相似文献
96.
Barry O'Donnell 《Pediatric surgery international》1991,6(4-5):266-268
Conclusion Endoscopic correction of vesicoureteric reflux is now established as a standard method of management. It should be offered as an alternative to all patients, but particularly to those in whom open bladder and ureteric surgery is contemplated. 相似文献
97.
Dr. Julie A. Porter Pharm.D. Dr. Barry L. Carter Pharm.D. FCCP Dr. Thomas P. Johnston Ph.D. Dr. Warren K. Palmer Ph.D. 《Pharmacotherapy》1995,15(1):92-98
A new animal model of hyperlipidemia is being developed using the nonionic surfactant poloxamer 407 (P-407). We investigated the impact of pravastatin on P-407-induced hyperlipidemia. Twenty rats received P-407 300 mg intraperitoneally to induce hyperlipidemia, and 20 control rats received saline injection. Pravastatin was administered orally to an equal number of rats in both groups using three different regimens. A fourth group did not receive pravastatin. At 24 hours after injection, total cholesterol levels in two of the pravastatin groups were 28% and 34% lower than those in animals that did not receive pravastatin (p≤0.01). At 48 hours, triglyceride levels were significantly lower in all pravastatin groups (21–44%) versus animals not receiving pravastatin. Pravastatin diminished the effects of P-407 on lipoproteins. This new animal model may be useful in screening for investigational antihyperlipidemic agents. 相似文献
98.
99.
Daniel L. Rubin Karen L. Falk Malcolm J. Sperling Michael Ross Sanjay Saini Barry Rothman Frank Shellock Elias Zerhouni David Stark Eric K. Outwater Udo Schmiedl Louis C. Kirby Judith Chezmar Terry Coates Miles Chang Jeffery M. Silverman Neil Rofsky Keith Burnett Julie Engel Stuart W. Young 《Journal of magnetic resonance imaging : JMRI》1997,7(5):865-872
The purpose of this study was to assess the effectiveness and safety of Gadolite Oral Suspension as a gastrointestinal (GI) contrast agent for MRI in a phase II and two phase III multicenter clinical trials. Gadolite was administered to 306 patients with known or suspected abdominal and/or pelvic disease. MRI with T1- and T2-weighted sequences was performed before and after ingestion. Efficacy was evaluated by having two masked readers rate the certainty of their MR diagnosis (0 = uncertain, 1 = probable, 2 = definite) on randomly presented pre- and post-Gadolite Oral Suspension enhanced images. Principal investigators also evaluated the images and established the final diagnosis. Vital signs, clinical chemistries, and adverse events were documented. Blood and urine samples were analyzed for gadolinium content to determine whether Gadolite Oral Suspension was absorbed systemically. Certainty in MR diagnosis increased significantly (P < .001) for both blinded readers between pre- and post-Gadolite images (.49–1.18 for reader 1; .46–1.53 for reader 2). Sensitivity, specificity, and accuracy also increased for both masked readers. No gadolinium was detected in blood or urine samples. There were no serious adverse events and no apparent drug-related trends in mean vital signs or laboratory values. Gadolite is a highly effective, safe, and well tolerated contrast agent for clinical use with MRI. 相似文献
100.
Dr. David H. Berger MD Barry W. Feig MD Donald Podoloff MD James Norman MD C. Wayne Cruse MD Douglas S. Reintgen MD Merrick I. Ross MD 《Annals of surgical oncology》1997,4(3):247-251
Background: If cutaneous lymphoscintigraphy (CL) is accurate in predicting the draining lymph node basins at risk from primary axial
melanomas, then regional metastases should only occur in those lymph node basins identified by CL.
Methods: This study is a retrospective review of patients undergoing CL for primary axial melanomas from June 1, 1985, until June
31, 1992. Data retrieved included age, gender, number of basins identified, location of basins identified, management of basins,
recurrence in lymphatics, development of distant disease, and long-term follow-up.
Results: A total of 181 patients underwent elective LND, and 48 patients (27%) had melanoma in the nodes within the dissected basin.
Of these 181 patients, seven developed nodal metastases as their site of first recurrence. All seven recurrences were seen
at sites dissected or at sites indicated by CL, which the primary surgeon elected not to treat initially. Of the 116 patients
observed, 16 (14%) developed lymph node metastases as their first site of recurrence. Fifteen of these 16 patients had their
site of lymph node metastases predicted by CL. In this study, CL predicted 98.6% of all lymph node metastases.
Conclusions: The high overall reliability of CL as demonstrated by long-term follow-up indicates that the information obtained by CL can
be reliably used to guide intervention. Initial evaluation of patients with high-risk cutaneous melanomas at sites with ambiguous
lymphatic drainage must include CL in order to determine the draining lymph node basins and to plan therapy.
Presented at the 47th Annual Cancer Symposium of The Society of Surgical Oncology, Houston, Texas, March 17–20, 1994. 相似文献